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Abstract
Background: Up to 18% of genital Chlamydia infections and 9% of Gonorrhoea infections in England are diagnosed
in Primary Care. Evidence suggests that a substantial proportion of these cases are not managed appropriately in line
with national guidelines. With the increase in sexually transmitted infections and the emergence of antimicrobial
resistance, their timely and appropriate treatment is a priority. We investigated feasibility and acceptability of extending
the National Chlamydia Screening Programme’s centralised, nurse-led, telephone management (NLTM) as an option for
management of all cases of chlamydia and gonorrhoea diagnosed in Primary Care.
Methods: Randomised feasibility trial in 11 practices in Bristol with nested qualitative study. In intervention practices
patients and health care providers (HCPs) had the option of choosing NLTM or usual care for all patients tested for
Chlamydia and Gonorrhoea. In control practices patients received usual care.
Results: One thousand one hundred fifty-four Chlamydia/gonorrhoea tests took place during the 6-month study, with
a chlamydia positivity rate of 2.6% and gonorrhoea positivity rate of 0.8%. The NLTM managed 335 patients. Interviews
were conducted with sixteen HCPs (11 GPs, 5 nurses) and 12 patients (8 female). HCPs were positive about the NLTM,
welcomed the partner notification service, though requested more timely feedback on the management of their
patients. Explaining the NLTM to patients didn’t negatively impact on consultations. Patients found the NLTM
acceptable, more convenient and provided greater anonymity than usual care. Patients appreciated getting a text
message regarding a negative result and valued talking to a sexual health specialist about positive results.
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Conclusion: Extension of this established NLTM intervention to a greater proportion of patients was both feasible and
acceptable to both patients and HCP, could provide a better service for patients, whilst decreasing primacy care
workload. The study provides evidence to support the wider implementation of this NLTM approach to managing
chlamydia and gonorrhoea diagnosed in primary care.
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Background
Chlamydia trachomatis and Neisseria gonorrhoeae are
the two most commonly diagnosed bacterial sexually
transmitted infections (STIs) in England, with 218,095
and 56,259 diagnoses reported in 2018, a 6 and 26% in-
crease since 2017 [1]. These infections are often diag-
nosed and treated late, meaning individuals have longer
to pass the infection to others and are more at risk of
developing long-term consequences. Chlamydia, which
is commonly asymptomatic, causes a substantial burden
of disease, in women particularly, including chronic pel-
vic pain, ectopic pregnancy and infertility [2–4]. Gonor-
rhoea treatment is threatened by the emergence of
antimicrobial resistance, which is now a global public
health priority for gonorrhoea [5–7], with three cases of
extensively drug resistant Neisseria gonorrhoeae identi-
fied in England in 2018 [8] and may become a future
issue for chlamydia [9]. National guidelines recommend
appropriate management includes timely testing and
treatment, with the right antibiotic, of both the patient
and partner(s) with a test of cure if gonorrhoea is de-
tected and a repeat test at 3–6 months in persons under
25 yrs. treated for chlamydia [10, 11]. Referral of con-
firmed gonorrhoea cases to a genitourinary medicine
(GUM) clinic, due to the complexities of management, is
also strongly recommended [11, 12]. These recommen-
dations are essential to prevent reinfection, onward
transmission, treatment failure, morbid sequelae, minim-
ise the pool of infection in the population and avert fur-
ther emergence of anti-microbial resistance [10, 11].
Budget cuts for sexual health services resulting in
fewer GUM clinics, means patients are not always able
to easily access specialist care [13]. The need to increase
STI testing outside of GUM clinics and integrate care
across providers has been emphasised [1, 14]. An in-
creasing proportion of STI management is now provided
by primary care [15]. However, primary care is not orga-
nised or resourced to easily deliver appropriate manage-
ment of STIs. Partner notification is challenging when
partners are patients of other practices and a substantial
proportion of STIs diagnosed in primary care may not
be managed in line with national guidance [5, 16, 17].
Research suggests only 5–11% of patients treated for
gonorrhoea in primary care receive the recommended
treatment and most cases were prescribed antibiotics no
longer recommended [5]. Antimicrobial resistance has
required two revisions to the UK national gonorrhoea
treatment guideline in the past 10 years [11, 18] and GPs
may not be aware of these revisions due to the infre-
quency of cases seen. There is also emerging evidence of
social inequalities in chlamydia infection, alongside more
established evidence of inequalities in gonorrhoea infec-
tion [19, 20]. Thus more cases of chlamydia and gonor-
rhoea are likely to be diagnosed in disadvantaged
communities where primary care services are already fa-
cing multiple demands [21].
The National Chlamydia screening programme
(NCSP) in England, introduced in 2003 offers women
and men, aged 15–24 years, opportunistic testing to
diagnose and control chlamydia infection [22], managed
locally by a centralised, telephone-based, nurse-led, STI
management service [22]. A key aim of the NCSP is sup-
porting testing within primary care [23], however this
management service had been under-utilised by primary
care [24]. We piloted extending the NCSP nurse-led
telephone-based service as an option for management of
all chlamydia/gonorrhoea primary care tests. We evalu-
ated the feasibility and acceptability to primary care
practitioners and patients of using this pathway.
Methods
Design
Primary care practices in Bristol and North Somerset
that request laboratory tests through the CliniSys Inte-
grated Clinical Environment (ICE) online system, were
invited to participate in the six-month randomised feasi-
bility trial, with cluster randomisation of primary care
practices to either intervention (nurse led telephone
management - NLTM) or control (usual care) arm
(Fig. 1). Practices were randomised by an independent
statistician on an 8:3 ratio (intervention: control) to in-
vestigate feasibility and acceptability of the intervention.
Local data suggested that a sample size of 10–15 prac-
tices would be required in order to generate sufficient
positive tests to assess feasibility.
Inclusion criteria were patients aged 18 years or over
undergoing testing for chlamydia or gonorrhoea at study
practices, and able to provide informed consent. There
were no additional exclusion criteria, however health
care professionals (HCPs) could exclude patients from
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NLTM where they felt this was inappropriate for clinical
or other reasons.
HCPs requested chlamydia and gonorrhoea tests
through the ICE online system. We adapted the ICE sys-
tem so intervention practices could record patient’s con-
sent for NLTM, anonymous data sharing and willingness
to be contacted about a qualitative interview. In control
practices, the ICE system allowed HCP to record pa-
tients’ consent to use anonymised medical records. The
testing laboratory notified requesting practices of test re-
sults. In the intervention arm, when management by
NLTM was chosen, the laboratory also securely emailed
patient details to the NLTM office. Patients with nega-
tive results received a text from the NLTM and positive
patients received a telephone call from a specialist nurse.
Any questions were answered, and appropriate treat-
ment via a nominated pharmacy or sexual health clinic
arranged along with partner treatment using either the
patient or provider led model. Patients with positive
gonorrhoea tests were referred to a GUM clinic. The
specialist nurse made three attempts to contact patients
and extra attempt(s) resulting from clinical assessment
of individual cases were also made. Where the nurse was
not able to contact the patient, the primary care practice
was informed. Data were collected from routine patient
record electronic systems.
Qualitative evaluation
Qualitative semi-structured interviews were conducted
with intervention patients and HCPs, to examine views
and experiences of NLTM and any barriers to its uptake.
Participants were purposively sampled regarding primary
care practice, age, gender, test result (patients); and pro-
fessional role (HCPs). Sample size was driven by the
concept of ‘information power’ [25], with continuous
Fig. 1 Study design
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assessment of information within our sample with re-
gard to meeting study objective.
A social scientist (EB) invited patients to participate in
interviews by phone and HCPs by email. Patient inter-
views were conducted by phone, and HCPs interviewed
face-to-face or by phone. With informed consent (writ-
ten, or audio for telephone interviews), interviews were
audio-recorded, transcribed verbatim, anonymised,
imported into NVivo 10 (QSR International) and ana-
lysed thematically [26]. A subset of transcripts were in-
dependently analysed by EB and JH to contribute to the
refinement of codes and maximise rigour. Codes were
built into broader categories and themes discussed by




11/27 (41%) of practices invited agreed to take part;
eight randomised to receive the intervention and three
to the control. In control practices 228 of349 tests were
submitted amongst recruited patients, mean age 32
years, 121 (34.7%) of patient tests were excluded from
the study: 62 patient ineligible, 5 assigned to the incor-
rect study arm and 54 declined permission for use of
anonymised medical records. In intervention practices
436 of805 tests were submitted amongst recruited pa-
tients, mean age 34.1 years, 369 (45.8%) patient tests
were excluded from the study: 77 clinically inappropri-
ate, 39 patient ineligible, 238 not consented to receive
NLTM and 15 were assigned to the incorrect study arm.
Interviews with HCPs indicated that few patients de-
clined consent to receive NLTM and it was more usual
for the consent process not to be completed due to time
pressure during consultations (see ‘Discussing nurse led
telephone management’ section).
During the study period (April – September 2015),
1154 Chlamydia/gonorrhoea tests took place, with 805
(70%) in the intervention and 349 (30%) in the control
arm (Fig. 2). Thirty tests were positive for chlamydia
(positivity rate of 2.6%), and 9 for gonorrhoea (positivity
rate of 0.8%). Three patients were positive for both chla-
mydia and gonorrhoea. The chlamydia positivity rate
was slightly lower (2.0, 95% CI: 1.1–3.3) in patients in-
cluded in the study compared to those excluded (3.5,
95% CI: 2.2–5.5). Approximately 23% (101/436) of pa-
tients who consented to receive NLTM were managed
via primary care (Fig. 2), qualitative interviews identified
that this was due to delays in data transfer to NLTM.
This initial issue was resolved by the laboratory auto-
mating sending relevant patient details to the NLTM for
action. In total the NLTM managed 335 patients, of
which 11 tested positive.
Qualitative evaluation
Sixteen HCPs (11 GPs, 5 nurses) and 12 patients (8 fe-
males; ages 22–50/average 32 years; 3 positive test re-
sults; ethnicity = 10 White British/1 White other/1
unknown) were interviewed (Table 1). Eleven patients
consented to NLTM and one patient was recorded as
having declined NLTM but agreed be interviewed. Pa-
tients were interviewed between 13 and 39 days (mean =
22 days) after the consultation when their test was taken.
Contact was attempted with a further 19 patients who
either then declined the interview or were not contact-
able by telephone despite repeated attempts. Two key
themes were developed from the analysis: ‘Views and ex-
periences of the primary care consultation’, and ‘Com-
municating and managing test results’. Findings are
illustrated using anonymised verbatim quotes.
Views and experiences of the primary care consultation
Consulting primary care for an STI
Patients valued consulting primary care for STIs. Some
female patients referred to stigma associated with being
seen using sexual health services as motivation for pre-
ferring primary care practice.
“… it’s a bit of a stigma because people know what
that specific [GUM] clinic is … and it’s one of those
things where, well, what if someone sees me that
knows me? They might, you know, and make as-
sumptions” (Patient 5).
Some patients who tested positive had consulted pri-
mary care previously regarding their symptoms before
being offered an STI test. Patients thought that oppor-
tunities had been missed to diagnose and treat them
earlier:
“I was hoping to have treatment. ‘Cos the first two
doctors I’d seen before then, they just kept passing it
off as thrush.” (Patient 7).
Discussing nurse led telephone management
Despite the online consent being completed, a minority
of patients had no recollection of NLTM being discussed
and or had not understood what it involved. Several pa-
tients mentioned that the consultation had been in the
context of stressful life events, which may have affected
their recollection:
“I can’t remember at all … I was distraught … at the
time when I spoke to my doctor.” (Patient 8)
HCPs mentioned having excluded a patient because
their first language was not English, because of patients’
learning difficulties and because the HCP wanted to see
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the patient for follow up regarding other issues. Another
GP decided not to discuss the intervention with some
patients she saw as being “ridiculously anxious already”
(GP 15). The commonest reason intervention practice
HCPs gave for not consenting patients related to time
pressure/frustration with ICE system online consent pro-
cedures, which also contributed to some patients being
assigned to an incorrect study arm. If an HCP felt too
Fig. 2 CONSORT Diagram
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busy to recruit, they chose the earliest possible exit op-
tion on the ICE system (e.g. ineligible or decline con-
sent). The ICE system was subsequently simplified
following feedback.
“Initially … . because it [ICE] was so clunky, and if you
were in a rush, it was quicker to press, “No” (GP 7)
Most HCP did not find explaining the NLTM to pa-
tients negatively impacted on consultations. HCPs re-
ported that the vast majority of their patients were
happy with NLTM and did not raise any questions or
concerns.
“I usually say, ‘The way positive results are going to
be managed is that somebody, with your consent,
will contact you from the screening service that
already deals with the screening programme, so
they’re well used to doing it.’ And most people say,
‘Oh yeah, that’s fine’.” (GP 5)
One GP did think explaining NLTM, along with the
need to check the phone number, would be more time
consuming “as opposed to, ‘Have your result, if it’s posi-
tive come back and see me and we’ll sort it out’” (GP 3).
However, they thought that some of this time might be
recouped in the longer term via NLTM managing re-
sults. Another GP was concerned that, if the STI test
was part of a broader diagnostic process, discussing
NLTM could put unwanted emphasis on the possibility
of a STI:
“If someone has just come in with a vaginal dis-
charge and they’ve got a regular partner, and you’re
saying, ‘I’m going to do some swabs for infection that
includes sexually transmitted infection but also in-
cludes non-sexually transmitted infection’, to then
have to really focus on, you know, ‘A nurse is going
to ring you if you’ve got chlamydia’, you’re sort of - it
escalates the anxiety about what’s going on. And
particularly patients with pelvic pain and stuff that
often are very anxious anyway. “(GP 15)
Communicating and managing test results
Health care professional uncertainties about intervention
procedures
Most HCP mentioned uncertainties regarding NLTM
procedures, including when the NLTM would contact
patients, and when, if at all, the HCP would be informed
about what care had been provided, or be notified if the
NLTM had not been able to contact the patient. A mi-
nority of HCP did not know that patients with negative
results were informed by text, and one GP had told pa-
tients that they still needed to call the practice. HCPs ac-
knowledged that if NLTM was usual care, rather than a
new initiative, they would be likely to have be more
confident that the patient was being appropriately
managed.
“if something’s new you’re just not sure how failsafe
it is, so I just told people, ‘You must phone us back
anyway. But, you know, basically you should receive
Table 1 Interview practice and participant characteristics
Practice Practice details (rounded practice population,







code, sex, age, test results)
A Population 6900
IMD 3rd decile
20 (18; 2) GP 1
GP 2
Patient 1, female, 50, negative
B Population 10,300
IMD 2nd decile
36 (34; 2) GP 3
GP 4
Patient 2, male, 22, Positive CT
Patient 3, male, 22, negative
C Population 9000
IMD 6th decile
32 (29; 3) GP 5
Nurse 6
Patient 4, female, 26, negative
D Population 16,000
IMD 6th decile
57 (56; 1) GP 7
Nurse 8
Patient 5, female, 35, negative
E Population 6000
IMD 1st decile
21 (19; 2) GP 9
Nurse 10
Patient 6, female, 37, positive CT
F Population 6300
IMD 1st decile
18 (17; 1) GP 11
GP 12
Patient 7, female, 29, positive NG
Patient 8, female, 48, negative
Patient 9, male, 25, negative
G Population 7500
IMD 1st decile
39 (37; 2) Nurse 13
Nurse 14
GP 15
Patient 10, f, 36, negative
H Population 7500
IMD 6th decile
14 (11; 3) GP 16 Patient 11, m, 24, negative
Patient 12, f, 35, negative
IMD Index of Multiple Deprivation, 1st decile represents the most deprived [27], CT Chlamydia trachomatis, NG Neisseria gonorrhoea. aAverage based on tests
submitted April–September 2014
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a phone call from, you know, the specialist hub.’”
(GP 16)
HCP retained a strong sense of personal responsibility
for the patients whose tests they had initiated:
“As the person taking the test, you kind of feel obli-
gated, by the way we’re trained, to follow it up. So, I
think that’s what I would do … I guess I might, after
the first few positives, I might just become more
confident and leave it.” (GP 4)
A minority of HCP reported that they had checked
that a patient had received results and infections were
being managed, and others said that they would have
done this if a positive result had come back:
“Well initially maybe it was me who wasn’t aware of
how things worked. I mean I think there was one
positive result which - I wasn’t sure whether it was
being acted upon or not. So, I kind of just did a pre-
scription and, you know, asked the receptionist to
find out if he has had a phone call. Because it was a
positive result, I just wanted to act upon it … the re-
ceptionist got back to me and said that, ‘No, he has
already had a [NLTM] phone call.’” (GP 1)
It was important to HCPs that there was a mechanism
to ensure that they were kept fully informed in a timely
manner regarding the care their patients were receiving:
“I didn’t want to just leave it, in case [NLTM] didn’t
get hold of her. … I think it would be nice to have
confirmation that.’” (Nurse 14)
Receiving results
Patients appreciated getting a text message regarding a
negative result and found this preferable to a ‘no news is
good news’ approach, or to having to try and contact
their practice to obtain results.
“I thought it was good because you get it straight
away then, isn’t it?…Trying to get through to a GP
surgery is a bit of a nightmare nowadays … it’s good,
just have it – peace of mind as well, everything was
alright.” (Patient 1)
Patients in general considered having a telephone con-
sultation regarding positive test results/treatment accept-
able, and significantly more convenient and timelier than a
face-to-face appointment. Some patients said that they
would feel more comfortable having a results conversation
by telephone as “In person it’s quite embarrassing” (Patient
3). Patient 4 thought that dealing with a positive result
would be easier if she was in her “own environment”, rather
than having to “hold it all together” in front of the GP.
Appeal of a ‘specialist’ nurse led service
Being contacted by ‘specialist’ nurses was considered at-
tractive by many patients, for a range of reasons. Some
patients expected usual care to involve being contacted
by primary care reception staff - when checking results
or making a follow-up appointment. In one case this in-
creased the patient’s concerns regarding confidentiality:
“…these receptionists live in the area. And I’m not
saying they’ll go and blab things out, but I don’t
want them to know my business. So, if it was dealt
with by someone who was specialised in that and
then you don’t even have to involve the doctor, that’s
way better.” (Patient 8)
Another patient had concerns about the level of ex-
pertise needed to communicate results:
“I always have a bit of doubt when I ring my GP sur-
gery to get results from tests, whether, because it’s
the receptionist telling me, I don’t – I do have a bit
of concern whether she’s misread them or not read
them properly. Whereas if it was someone who spe-
cialised, you know, in that kind of thing and they’re
ringing you, then you know, I think you just have a
bit more confidence.” (Patient 5)
Some patients also mentioned the appeal of receiving
results from someone who could immediately answer
questions and arrange treatment. Patients expected spe-
cialist nurses to have more expertise than GPs, which
was reassuring:
“If it was with a specialist it would probably make you
feel better. So, the doctor, when I was speaking to her,
she didn’t really know a lot. So sometimes, if they don’t
know a lot and they’re not very certain themselves, it
makes you uncertain. Whereas if you get a phone call
from someone that knows what they’re talking about,
it makes you a little bit more at ease.” (Patient 4)
Patients were also aware of GP workloads, and expected
a specialist nurse to have more time to discuss results:
“I’d prefer to speak to someone whose specific role
was to speak to people about this, rather than a GP
who has got many other responsibilities and might
not give you the right time to discuss it.” (Patient 11)
HCPs referred to the fact that the NLTM service was
already in place and working well for younger patients
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via the NCSP and saw extending this to everyone as
positive, being able to provide timelier follow-up, and
better partner notification.
“But it’s quite nice to know that if it was positive
then there’s another service going into the notifica-
tion and making sure they get their treatment and
stuff. Because … sometimes it’s quite hard to get hold
of a patient and, you know, I’m only in here two
days a week.” (GP 15)
Views on partner notification
HCPs expressed the view that partner notification in pri-
mary care could be “a bit haphazard” (GP 2), and that
NLTM would be better placed to manage this.
“[GP’s name] who was very good … but he said actu-
ally, more often than not, he would refer [partner
notification]. But it’s simply because of time man-
agement that he just didn’t have time to sort it all
out, and we didn’t have anybody in admin or any
nurse, you know, that would sort of – he could palm
that off.” (Nurse 13)
While no patients objected to being asked for details
of partners, views on the best way to manage partner no-
tification varied. While some wished to notify partners
themselves, others who expressed a view regarding
whether this discussion was with their GP or the NLTM
were either neutral, or preferred NLTM:
Patient 8: I’d be quite happy, if I knew I’d got some
infection or something I’d be quite happy to say,
‘Well it’s this person, that person or that person,’ you
know.
Interviewer: And would you find it easier to be talk-
ing to a specialist nurse about that or to be talking
to your GP?
Patient 8: Specialist nurse definitely, yeah.
Discussion
The majority of eligible patients in intervention practices
were managed via NLTM. This demonstrates the feasi-
bility of implementing an alternative clinical pathway
allowing primary healthcare to elect for patients testing
for chlamydia and gonorrhoea to be managed remotely
by specialist nurses. NLTM was acceptable to both HCP
and patients. Patients perceived benefits of NLTM to be
a faster and a more proactive approach to communicat-
ing test results. The convenience and greater anonymity
of a telephone consultation and being managed by a sex-
ual health specialist was welcomed. HCPs expected the
impact of NLTM on workload in primary care to be
positive and to provide benefits for patients in relation
to better and timely follow-up - particularly with regards
to partner notification, which is essential for comprehen-
sive case management [10, 11, 28]. We identified a need
for improved clarity of NLTM pathway process for both
patients and HCPs, and HCPs also expressed a desire for
timely notification of actions taken by the NLTM. With-
out such feedback, HCPs often felt obligated to follow
up positive test results themselves.
Strengths and limitations
Qualitative interviews, with constant communication
within the study team, helped to identify issues early and
iteratively inform intervention implementation. Al-
though 40% of eligible patients did not provide consent
for NLTM, qualitative findings suggest time to conduct
consent and frustration with consent procedures, rather
than patients refusing consent, was the main reason for
this. Our data suggests that Chlamydia test positivity
was higher amongst patients excluded from the study.
However, the study lacked power to estimate such a dif-
ference and there was considerable overlap of confidence
intervals of the relevant prevalence estimates. A minority
of patients were assigned to the incorrect study arm
through the ICE interface when requesting chlamydia
and gonorrhoea tests through the ICE online system.
The initial cumbersomeness of the ICE system also
caused frustration for HCP when conducting online con-
sent. Interview findings demonstrates that in some cases
patient consent was not obtained due to time pressures
of practitioners rather than participant choice, particu-
larly in intervention practices.
We recorded a chlamydia positivity rate of 2.6%, which
is lower than that observed in the NCSP and probably
reflects that the population tested had a mean age of 33
years, as chlamydia prevalence declines with age over 25
years [29]. Primary care can play an important role in
opportunistic testing of at-risk individuals for chlamydia
and gonorrhoea. Patients in our study valued consulting
primary care for STIs in line with previous research [30],
as GUM clinics may remain a stigmatised service for
some [31]. However, our findings suggest opportunities
may continue to be missed to diagnoses STIs in primary
care, with research suggesting up to 40% of those attend-
ing GUM clinics, initially presenting at their general
practice [32, 33]. Patients valued being contacted by a
sexual health specialist via the NLTM over a GP, who
may have less knowledge of STIs. Patient perceptions
may be well founded, as a recent survey revealed that
while 88% of GPs were confident in treating chlamydia,
only 27% were confident treating gonorrhoea [34].
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Implications for research and/or practice
Our study suggests that the NLTM has the potential to
provide a better service for patients whilst decreasing
primary care workload and contribute to better use of
clinical resources and better patient outcomes. Of par-
ticular benefit will be the improvement of partner notifi-
cation and treatment of infected partner(s), and repeat
testing 3 months after treatment for persons under 25
years old with chlamydia which can be facilitated
through the NLTM and which may otherwise be
overlooked.
Whilst an RCT is ideal to test the effectiveness of
NLTM versus usual care, as NLTM approaches are
already being implemented in this fast-moving area, real
world evaluation based on mixed methods including
routine data is needed.
Several improvements to the implementation process,
to support HCPs and safeguard patients, were identified.
HCPs often did not find it feasible to use the online ICE
system during the consultation, thus the interface de-
sign, and training, should take this into account. The
process of result notifications from the laboratory to the
NLTM should be automated, and a feedback mechanism
put in place so HCPs can check when their patients have
been contacted about results and appropriately
managed.
Conclusions
There is sufficient evidence to support the wider imple-
mentation of this NLTM approach to managing com-
mon STI diagnosed in primary care. The fact that such
implementation is already taking place across England
suggests that large scale experimental evaluation of the
pathway may now be infeasible. This notwithstanding,
“real world” evaluation of the cost-effectiveness of the
remote, nurse-led pathway compared to practice-based
management is still needed and could be undertaken at
relatively low cost using routine data.
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